pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 1·1 min read
save

ASCO meeting highlights grief alongside cancer data, honoring late oncologist Amy Lin

Jun 1, 2026·read at STAT ↗Neutral

At the annual American Society of Clinical Oncology meeting, scientists presented abundant new cancer data, but this year the program also gave space to the emotional side of oncology.

Outgoing president Eric Small opened the conference by recalling his partner, UCSF oncologist Amy Lin, who died in December from metastatic clear cell ovarian cancer, a rare disease with limited treatment options.

Small invited grief specialist David Kessler to speak about compassionate end-of-life care, underscoring how loss shapes the practice of cancer treatment.

The focus on grief offered attendees a reminder that caring for patients extends beyond clinical outcomes.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to grief”

read at STAT ↗
466 words · retrieved Jun 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2
drugs
Rare Disease2
topics
Oncology15Rare Disease2HematologyNSCLCPulmonology

related stories

  • 4d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 10Andy Plump, architect of Takeda’s R&D overhaul, to retire next yearBioPharma Dive
  • Aug 17AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blowBioSpace
  • Aug 17AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blowBioSpace
  • Jul 29Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushBioPharma Dive